The Carlyle Group said on Monday it has acquired a significant minority stake in North Augusta, South Carolina-headquartered Ambio Holdings from specialist healthcare fund MVM Partners.
Founded in 2007 by Chris Bai, Ambio develops and manufactures peptide active pharmaceutical ingredients.
Both target and buyer hope the deal will be a first step towards expansion in China, where a burgeoning middle class and disquiet over a dysfunctional medical system are creating a host of opportunities for investors.
“Carlyle Asia team’s strong local connections will help expedite our growth strategies in China,” Bai said.
Equity for the investment came from Carlyle...